Jamaal T. Lesane
Known title: EVP and General CounselCIK: 0001918764
Associated companies
this person other insiders at MSGS
Transaction History
| MSGS | ▲ Buy | Option Exercise | 843 | $0 | 9/15/2026 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 1,248 | $0 | 9/15/2026 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 1,251 | $0 | 9/15/2026 | View on chart |
| MSGS | ▼ Sell | Tax Withholding | 1,847 | $726K | 9/15/2026 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 2,462 | $0 | 9/15/2026 | View on chart |
| MSGS | ▼ Sell | Tax Withholding | 1,361 | $535K | 9/15/2026 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 830 | $0 | 9/15/2025 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 842 | $0 | 9/15/2025 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 1,248 | $0 | 9/15/2025 | View on chart |
| MSGS | ▼ Sell | Tax Withholding | 1,613 | $340K | 9/15/2025 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 2,655 | $0 | 9/15/2025 | View on chart |
| MSGS | ▼ Sell | Tax Withholding | 1,468 | $310K | 9/15/2025 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 345 | $0 | 9/13/2024 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 53 | $0 | 9/13/2024 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 829 | $0 | 9/13/2024 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 842 | $0 | 9/13/2024 | View on chart |
| MSGS | ▼ Sell | Tax Withholding | 1,142 | $234K | 9/13/2024 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 1,131 | $0 | 9/13/2024 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 173 | $0 | 9/13/2024 | View on chart |
| MSGS | ▼ Sell | Tax Withholding | 637 | $130K | 9/13/2024 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 344 | $0 | 9/15/2023 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 53 | $0 | 9/15/2023 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 1,097 | $0 | 9/15/2023 | View on chart |
| MSGS | ▼ Sell | Tax Withholding | 475 | $85K | 9/15/2023 | View on chart |
| MSGS | ▼ Sell | Tax Withholding | 867 | $154K | 9/15/2023 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 829 | $0 | 9/15/2023 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 345 | $0 | 9/15/2023 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 198 | $0 | 9/15/2022 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 344 | $0 | 9/15/2022 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 344 | $0 | 9/15/2022 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 52 | $0 | 9/15/2022 | View on chart |
| MSGS | ▼ Sell | Tax Withholding | 375 | $58K | 9/15/2022 | View on chart |
| MSGS | ▲ Buy | Option Exercise | 610 | $0 | 9/15/2022 | View on chart |
| MSGS | ▼ Sell | Tax Withholding | 245 | $38K | 9/15/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Knicks' role in Foot Locker's turnaround discussed
Recent coverage examines how the New York Knicks may support Foot Locker's efforts to improve its business performance. This is relevant to Madison Square Garden Sports Corp. because the Knicks are a major asset within the MSGS portfolio. While the news focuses on a partner's strategy, it highlights the broader commercial ecosystem surrounding the team.
Knicks' role in Foot Locker's turnaround discussed. Recent coverage examines how the New York Knicks may support Foot Locker's efforts to improve its business performance. This is relevant to Madison Square Garden Sports Corp. because the Knicks are a major asset within the MSGS portfolio. While the news focuses on a partner's strategy, it highlights the broader commercial ecosystem surrounding the team.